Axelyf, Inc. (Axelyf ehf)

AktivBioTechBrookline, USGegr. 2022Website

Axelyf is a biotechnology company developing novel lipid nanoparticles (LNPs) and related lipid technologies for safe and efficient delivery of RNA-based therapeutics. It focuses on proprietary ionizable AXL-lipids and surface chemistries to improve potency, biodegradability and extrahepatic delivery, and uses AI models (ANNA) to predict and optimize LNP performance. Founded in 2022, with headquarters in Brookline, MA and R&D in Hafnarfjörður, Iceland.